Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Clinical Trials Arena
Fri, 06/6/25 - 12:03 pm
Avenzo Therapeutics
AVZO-023
breast cancer
clinical trials
Perspective Therapeutics brings energy to the radiopharma world
BioSpace
Fri, 06/6/25 - 12:02 pm
Perspective Therapeutics
radiopharma
neuroendocrine tumors
ASCO 2025
Valneva reports data from Phase II chikungunya vaccine trial in children
Clinical Trials Arena
Fri, 06/6/25 - 11:55 am
Valneva
VLA1553-221
chikungunya virus
vaccines
clinical trials
CEPI
Ixchiq
Medtronic removes tracheostomy tubes due to dislodging risk
Medtech Dive
Fri, 06/6/25 - 11:51 am
Medtech
Medtronic
tracheostomy tubes
device recalls
Owens & Minor spikes $1.36B Rotech buyout over regulatory barriers
Medtech Dive
Fri, 06/6/25 - 11:49 am
Owens and Minor
M&A
Rotech
Otsuka's kidney disease drug halves UPCR levels in phase 3 study
Fierce Biotech
Fri, 06/6/25 - 11:47 am
Otsuka
kidney disease
clinical trials
sibeprenlimab
With ADCs on the rise, drugmakers embrace a new oncology pillar
Pharma Voice
Fri, 06/6/25 - 11:36 am
oncology
ASCO 2025
antibody-drug conjugates
Daiichi Sankyo
AstraZeneca
Enhertu
Bayer trial combines two top drugs for kidney disease
Pharmaphorum
Fri, 06/6/25 - 11:34 am
Bayer
finerenone
Boehinger Ingelheim
Eli Lilly
Jaridance
chronic kidney disease
diabetes
Digital health firm Omada prices $150m IPO
Pharmaphorum
Fri, 06/6/25 - 11:32 am
Omada Health
IPOs
digital health
Pharmaceutical Sales - Territory Manager - GI Specialty - Eli Lilly and Company - South Bend, Indiana, United States
Fri, 06/6/25 - 11:18 am
uniQure’s regulatory progress sparks optimism for ‘desperate’ Huntington’s space
BioSpace
Thu, 06/5/25 - 10:01 pm
uniQure
Huntington's disease
AMT-130
gene therapy
Newly proposed EU drug regulations a 'missed opportunity' to support innovation, industry says
Fierce Pharma
Thu, 06/5/25 - 09:58 pm
Europe
innovation
regulatory
EFPIA
Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal
BioPharma Dive
Thu, 06/5/25 - 09:56 pm
Cullinan Oncology
autoimmune diseases
T cell engagers
Genrix Bio
US COVID vaccine recommendations sow confusion among doctors, insurers
MSN/Reuters
Thu, 06/5/25 - 09:54 pm
HHS
Robert F Kennedy Jr.
COVID-19
vaccines
US Health Secretary Kennedy looks to fast-tracking approvals for rare disease drugs
Yahoo/Reuters
Thu, 06/5/25 - 09:52 pm
HHS
Robert F Kennedy Jr.
FDA
fast track
Rare Diseases
June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Thu, 06/5/25 - 11:44 am
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Stat
Thu, 06/5/25 - 11:33 am
GLP-1 agonists
diabetes
age-related macular degeneration
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
BioPharma Dive
Thu, 06/5/25 - 11:30 am
ASCO 2025
cancer
oncology
bispecific antibodies
funding
breast cancer
Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer
Xtalks
Thu, 06/5/25 - 11:11 am
Incyte
Zynyz
anal cancer
FDA
Chasing Sarepta, RegenXBio links DMD gene therapy to improved outcomes
Fierce Biotech
Thu, 06/5/25 - 11:01 am
Regenxbio
DMD
gene therapy
Sarepta Therapeutics

Pages